Prescription Drug User Fee Act (PDUFA) target date of October 2026 -- -- Submission supported by CESSA Phase 3 trial results demonstrating statistically significant rates of clinical remission in ...

Canasa (mesalamine) is a brand-name suppository that’s prescribed for ulcerative proctitis in adults. The cost of the drug, with and without insurance, can depend on several factors, such as whether ...

Objective: Treatment of chronic functional constipation is difficult. Both oral and topical laxatives may fail to adequately relieve symptoms, and there is risk of adverse effects such as functional ...

Canasa (mesalamine) is a brand-name suppository that’s prescribed for ulcerative proctitis in adults. As with other drugs, Canasa can cause side effects, such as dizziness and rectal pain. Canasa can ...

The U.S. and Canada suppositories market is projected to reach $1.3 billion by 2035, reflecting increasing acceptance of this dosage form. LGM Pharma’s investment will strengthen both infrastructure ...